http://goldbamboo.com/ Sinusitis News from GoldBamboo.com en-us © 2005, Gold Bamboo LLC, All Rights Reserved http://goldbamboo.com/news-a220342.html The government  restricted use of an antibiotic linked to rare reports of severe liver problems, including several deaths, saying the drug now should be used only to treat pneumonia but not less serious bacterial infections like bronchitis and sinusitis. Mon, 12 Feb 2007 05:14 EST http://goldbamboo.com/news-a220259.html WASHINGTON (Reuters) - U.S. regulators warned on Monday that Sanofi-Aventis SA's antibiotic Ketek should no longer be used to treat patients with sinusitis and bronchitis, saying the controversial drug carries too many risks. Mon, 12 Feb 2007 04:17 EST http://goldbamboo.com/news-a220283.html WASHINGTON (Reuters) - Sanofi-Aventis SA's antibiotic Ketek should no longer be used to treat sinusitis and bronchitis, U.S. officials warned on Monday, saying the controversial drug was too risky to treat those diseases. Mon, 12 Feb 2007 06:08 EST http://goldbamboo.com/news-a220830.html The Food and Drug Administration (FDA) today announced revisions to the labeling for the antibiotic Ketek (telithromycin) designed to improve the safe use of Ketek by patients. The changes include the removal of two of the three previously approved indications - acute bacterial sinusitis and acute bacterial exacerbations of chronic bronchitis - from the drug's label. [click link for full article] Thu, 15 Feb 2007 08:00 EST http://goldbamboo.com/news-a220469.html The US Food and Drug Administration (FDA) has revised the label warnings on the antibiotic Ketek, to improve safe use by patients. Ketek is the brand name of Telithromycin and is manufactured by Sanofi-Aventis.The FDA has removed approval of the drug for treatment of acute bacterial infections associated with sinusitis and chronic bronchitis. [click link for full article] Tue, 13 Feb 2007 01:00 EST